These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 39404416)

  • 1. Systematic Comparison of CRISPR and shRNA Screens to Identify Essential Genes Using a Graph-Based Unsupervised Learning Model.
    Ding Y; Denomy C; Freywald A; Pan Y; Vizeacoumar FJ; Vizeacoumar FS; Wu FX
    Cells; 2024 Oct; 13(19):. PubMed ID: 39404416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Essential Genes Using Sequential CRISPR and siRNA Screens.
    DeHart L; Yockey OP; Bakke J
    Methods Mol Biol; 2022; 2377():89-107. PubMed ID: 34709612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic comparison of CRISPR/Cas9 and RNAi screens for essential genes.
    Morgens DW; Deans RM; Li A; Bassik MC
    Nat Biotechnol; 2016 Jun; 34(6):634-6. PubMed ID: 27159373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes.
    Evers B; Jastrzebski K; Heijmans JP; Grernrum W; Beijersbergen RL; Bernards R
    Nat Biotechnol; 2016 Jun; 34(6):631-3. PubMed ID: 27111720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic Regions.
    Munoz DM; Cassiani PJ; Li L; Billy E; Korn JM; Jones MD; Golji J; Ruddy DA; Yu K; McAllister G; DeWeck A; Abramowski D; Wan J; Shirley MD; Neshat SY; Rakiec D; de Beaumont R; Weber O; Kauffmann A; McDonald ER; Keen N; Hofmann F; Sellers WR; Schmelzle T; Stegmeier F; Schlabach MR
    Cancer Discov; 2016 Aug; 6(8):900-13. PubMed ID: 27260157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SeqCor: correct the effect of guide RNA sequences in clustered regularly interspaced short palindromic repeats/Cas9 screening by machine learning algorithm.
    Liu X; Yang Y; Qiu Y; Reyad-Ul-Ferdous M; Ding Q; Wang Y
    J Genet Genomics; 2020 Nov; 47(11):672-680. PubMed ID: 33451939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas9 screens reveal common essential miRNAs in human cancer cell lines.
    Merk DJ; Paul L; Tsiami F; Hohenthanner H; Kouchesfahani GM; Haeusser LA; Walter B; Brown A; Persky NS; Root DE; Tabatabai G
    Genome Med; 2024 Jun; 16(1):82. PubMed ID: 38886809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CEDA: integrating gene expression data with CRISPR-pooled screen data identifies essential genes with higher expression.
    Zhao Y; Yu L; Wu X; Li H; Coombes KR; Au KF; Cheng L; Li L
    Bioinformatics; 2022 Nov; 38(23):5245-5252. PubMed ID: 36250792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo CRISPR screening for novel noncoding RNA functional targets in glioblastoma models.
    Attenello FJ; Tsung K; Bishara I; Loh YE; Chen TC
    J Neurosci Res; 2021 Sep; 99(9):2029-2045. PubMed ID: 33969526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of potent shRNAs with a sequential classification algorithm.
    Pelossof R; Fairchild L; Huang CH; Widmer C; Sreedharan VT; Sinha N; Lai DY; Guan Y; Premsrirut PK; Tschaharganeh DF; Hoffmann T; Thapar V; Xiang Q; Garippa RJ; Rätsch G; Zuber J; Lowe SW; Leslie CS; Fellmann C
    Nat Biotechnol; 2017 Apr; 35(4):350-353. PubMed ID: 28263295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovering false negatives in CRISPR fitness screens with JLOE.
    Dede M; Hart T
    Nucleic Acids Res; 2023 Feb; 51(4):1637-1651. PubMed ID: 36727483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling CRISPR-Cas13d on-target and off-target effects using machine learning approaches.
    Cheng X; Li Z; Shan R; Li Z; Wang S; Zhao W; Zhang H; Chao L; Peng J; Fei T; Li W
    Nat Commun; 2023 Feb; 14(1):752. PubMed ID: 36765063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting.
    Aguirre AJ; Meyers RM; Weir BA; Vazquez F; Zhang CZ; Ben-David U; Cook A; Ha G; Harrington WF; Doshi MB; Kost-Alimova M; Gill S; Xu H; Ali LD; Jiang G; Pantel S; Lee Y; Goodale A; Cherniack AD; Oh C; Kryukov G; Cowley GS; Garraway LA; Stegmaier K; Roberts CW; Golub TR; Meyerson M; Root DE; Tsherniak A; Hahn WC
    Cancer Discov; 2016 Aug; 6(8):914-29. PubMed ID: 27260156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choosing CRISPR-based screens in cancer.
    Marx V
    Nat Methods; 2017 Mar; 14(4):343-346. PubMed ID: 28362439
    [No Abstract]   [Full Text] [Related]  

  • 15. GuideScan software for improved single and paired CRISPR guide RNA design.
    Perez AR; Pritykin Y; Vidigal JA; Chhangawala S; Zamparo L; Leslie CS; Ventura A
    Nat Biotechnol; 2017 Apr; 35(4):347-349. PubMed ID: 28263296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Screening Approach for the Dissection of Cellular Regulatory Networks of NF-κB Using Arrayed CRISPR gRNA Libraries.
    O'Shea P; Wildenhain J; Leveridge M; Revankar C; Yang JP; Bradley J; Firth M; Pilling J; Piper D; Chesnut J; Isherwood B
    SLAS Discov; 2020 Jul; 25(6):618-633. PubMed ID: 32476557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized RNA-targeting CRISPR/Cas13d technology outperforms shRNA in identifying functional circRNAs.
    Zhang Y; Nguyen TM; Zhang XO; Wang L; Phan T; Clohessy JG; Pandolfi PP
    Genome Biol; 2021 Jan; 22(1):41. PubMed ID: 33478577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and Design of Genome-Wide CRISPR/SpCas9 Knockout Screens.
    Hart T; Tong AHY; Chan K; Van Leeuwen J; Seetharaman A; Aregger M; Chandrashekhar M; Hustedt N; Seth S; Noonan A; Habsid A; Sizova O; Nedyalkova L; Climie R; Tworzyanski L; Lawson K; Sartori MA; Alibeh S; Tieu D; Masud S; Mero P; Weiss A; Brown KR; Usaj M; Billmann M; Rahman M; Constanzo M; Myers CL; Andrews BJ; Boone C; Durocher D; Moffat J
    G3 (Bethesda); 2017 Aug; 7(8):2719-2727. PubMed ID: 28655737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimized combinatorial CRISPR screens identify genetic interactions in autophagy.
    Diehl V; Wegner M; Grumati P; Husnjak K; Schaubeck S; Gubas A; Shah VJ; Polat IH; Langschied F; Prieto-Garcia C; Müller K; Kalousi A; Ebersberger I; Brandts CH; Dikic I; Kaulich M
    Nucleic Acids Res; 2021 Jun; 49(10):5684-5704. PubMed ID: 33956155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification.
    Deans RM; Morgens DW; Ökesli A; Pillay S; Horlbeck MA; Kampmann M; Gilbert LA; Li A; Mateo R; Smith M; Glenn JS; Carette JE; Khosla C; Bassik MC
    Nat Chem Biol; 2016 May; 12(5):361-6. PubMed ID: 27018887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.